MTOR and metabolic dysfunction-associated steatohepatitis: Beyond the synergistic enhancement of PD-L1 and EMT, other immune evasion mechanisms mediated by the PI3K/Akt/mTOR pathway may also be amplified in the unique pathological environment of IR/MASH.